《半日總結》恆指挫446點 醫藥股捱沽 阿里跌6%
美國聯儲局一如預期加息0.75厘,惟聯儲局主席鮑威爾在記者會中不斷釋出「鷹派」言論道指隔晚(2日)反覆收挫505點或近1.6%。港股今日(3日)早段跟隨外圍低開,恆指一度挫525點低見15,301點,半日收報15,381點,跌446點或2.8%;國指跌163點或3.1%,報5,191點;恆生科技指數挫114點或3.6%,報3,041點。大市半日成交總額561.59億元,滬、深港通南下交易半日淨流入27.28億及23.98億元人民幣。
醫藥股捱沽,康希諾-B(06185.HK)瀉26.5%,公司預期吸入用新冠疫苗不會帶來公司業績的大幅增長,此外富瑞降其評級至「跑輸大市」,削目標價至106元。君實生物(01877.HK)挫12.8%。石藥(01093.HK)跌10.1%,為表現最差藍籌股。中生製藥(01177.HK)跌5.9%。復星醫藥(02196.HK)跌5%。藥明生物(02269.HK)跌4.1%。
科技股受壓,騰訊(00700.HK)跌3.5%報222.6元,公司獲市監局批准與聯通設立混改新公司,聯通(00762.HK)逆市升2.7%。阿里-SW(09988.HK)跌6%,網易-S(09999.HK)跌6.7%,百度-SW(09888.HK)跌5.9%,嗶哩嗶哩(09626.HK)及京東-SW(09618.HK)各跌5.4%及5.1%。美團-W(03690.HK)、小米-W(01810.HK)及快手-W(01024.HK)各跌2.3%至3.2%。
據報深圳有樓盤連續兩日出現「日光盤」(即日售罄),內房股個別發展,龍光(03380.HK)升4.2%,綠城中國(03900.HK)升2.9%,旭輝(00884.HK)升2.4%,惟華潤置地(01109.HK)跌4%,萬科(02202.HK)、中海外(00688.HK)、碧桂園(02007.HK)及合景泰富(01813.HK)各跌1.2%至3.2%。
車股吉利(00175.HK)跌4.1%。比亞迪(01211.HK)跌1.6%,公司否認一汽奧迪採購公司混動系統。電動車股蔚來-SW(09866.HK)合肥兩間廠房已復產,惟股價仍挫8%。小鵬-W(09868.HK)跌2.8%,理想-W(02015.HK)則升1.8%。
濠賭股偏軟,金沙(01928.HK)跌6.1%,銀娛(00027.HK)跌2.5%。體品股李寧(02331.HK)及安踏(02020.HK)各跌5.4%及5.3%。至於重磅金融股匯控(00005.HK)跌2.5%,港交所(00388.HK)跌2.4%,友邦(01299.HK)跌1.9%,建行(00939.HK)跌1.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.